Val­ne­va and Pfiz­er eye 2027 launch for part­nered Ly­me dis­ease vac­cine

Val­ne­va is eye­ing a 2027 launch for its Pfiz­er-part­nered Ly­me dis­ease vac­cine, CEO Thomas Lin­gel­bach said Thurs­day dur­ing the com­pa­ny’s in­vestor day.

Pfiz­er has sole …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER